SUMMARY The treatment of choice in obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP). Mandible advancement splint (MAS) offers an option for patients with mild or moderate OSA, who refuse or are unable to tolerate CPAP. The aim of the study was to find predictive factors in OSA for MAS therapy. The study group comprised 96 consecutive OSA patients who were sent for MAS therapy during 2008. Data were collected on the patients' general and dental condition, diagnosis, and treatment for OSA. Panoramic and cephalometric radiographs were analysed. The treatment compliance rate and problems with the use of the MAS were recorded. This rate was 57% and the significant affecting factors were protrusion of the mandible with MAS during the adaptation to the appliance as well as shorter maxillary and mandible lengths. The compliance of the MAS therapy was best in patients with short maxilla and mandible, which should be taken into consideration when planning MAS therapy for OSA patients. Finally, a sleep study should be part of the follow-up in this patient population.
Introduction
The treatment of choice in obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP) therapy (Giles et al., 2006) . Although mandible advancement splint (MAS) appliances are shown to be less effective in reducing the apnea-hypopnea index (AHI), compared with CPAP therapy, they offer an option for patients with mild or moderate OSA, who refuse or are unable to tolerate CPAP therapy. MAS reduces daytime sleepiness and improves AHI by protruding the mandible and maintaining pharyngeal airway open (Lim et al., 2004; Kushida et al., 2005; Johal et al., 2011) .
Recently, it has been reported that the MAS is relatively well tolerated even in patients with a previous temporomandibular disorder (Perez et al., 2012) and approximately 56-70% of OSA patients beginning MAS therapy tolerate the appliance and their symptoms diminish (Lim et al., 2004; Kushida et al., 2005) The most crucial factor for the success rate of MAS treatment is the quantity of mandible advancement (Hoffstein, 2007) . No definite conclusions can be drawn regarding the type of MAS, i.e. materials used, method for fabrication, and design features that have the most beneficial influence on subjective treatment efficacy or cause fewer sideeffects for the patients (Hoffstein, 2007; Hoekema et al., 2008; Ahrens et al., 2010) . Furthermore, only a few predictive factors are known for successful use of MAS therapy.
Our aim was to analyse a series of OSA patients at a single academic centre in order to find predictive factors for the compliance of MAS therapy.
Patients and methods

Patients
We retrospectively reviewed the clinical records of all OSA patients sent for MAS therapy in year 2008 to the Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital (HUCH), Helsinki, Finland, with a health-care district including approximately 1.5 million inhabitants.
Data were collected on gender, age, general health, body mass index (BMI), former treatment of OSA, information of CPAP treatment, AHI, oxygen desaturation index (ODI 4 ), and Epworth sleepiness scale (ESS). Data for clinical dental examination, bite muscles, temporomandibular joints (TMJ), and panoramic and cephalometric radiographs were collected. Referring to our clinical experiences, we considered a period of 6 months is suitable to evaluate the compliance of the MAS therapy. We therefore arbitrary considered a patient as adherent if he or she regularly used the MAS for at least 6 months. Problems with the use of the MAS were also recorded. The protocol of this retrospective study was reviewed and approved by the Institutional Research Ethics Board (3 June 2010, §89).
Sleep studies
Sleep studies were performed by a type III (American Academy of Sleep Medicine classification 2005; Colson et al. 2007, p. 2) ambulatory polygraph Embletta (Embla, Denver, Colorado, USA). Apnea was defined as the complete cessation of nasal airflow for at least 10 seconds. Hypopnea was defined as a reduction in nasal airflow of at least 50% for at least 10 seconds, accompanied by a decrease in saturation of peripheral oxygen (SpO 2 ) of at least 3%.
CPAP therapy
The indication for CPAP therapy trial was an AHI greater than 15/h or an AHI greater than 5/h along with a considerable daytime sleepiness.
Radiography
Pre-treatment panoramic and cephalometric radiographic (CR) analyses were performed. The soft tissue filter was adjusted for the profile of the pharyngeal region to improve soft tissue imaging. The exposure was performed at the end of expiration with teeth in occlusion. The enlargement of CR was corrected before digitizing. The landmarks identified from CR images were digitized by two authors (TI and SA), registered on a computer, and then linear and angular variables were calculated (Viewbox † 3.1-Cephalometric Software, dHal Software, Kifissia, Greece). The skeletal, soft tissue, and pharyngeal reference points and lines are presented in Figure 1 (Virkkula et al., 2003; Bäck et al., 2009; Ahrens et al., 2010) .
MAS therapy
Inter-occlusal wax bite registration was performed to obtain approximately 70% of the maximal protrusion of mandible. Alginate impressions of the upper and lower dentition were obtained to make working models, which were surveyed to construct a customized MAS. The appliance has maxillary and mandible acrylic splints with bilateral telescopic arms preventing retrusion of mandible (Clark and Nakano, 1989) . The follow-up visits for the patient with the appliance were set up after 1 month, annually, and then on demand. To find the ideal protrusion, metallic insets ranging from 1 to 3 mm could be added to the MAS during the follow-up.
Ideal patient
In order to target the MAS treatment better to those patients who would tolerate the appliance and thus benefit from it as well as to decrease the cost of MAS treatment at our institution, an ideal patient model for the treatment was developed including general, clinical, and radiological parameters. The virtual patient received one point for each character unfulfilled, and the ideal patient received zero points (Table 1) .
Statistics
We reported values as medians with ranges for descriptive purposes. The difference between the successful and failed MAS groups was evaluated using the Mann-Whitney test for continuous variables and Kruskal-Wallis test for categorical data. The correlation between the pre-treatment findings and the compliance was determined by using nonparametric Spearman correlation coefficients. Results were generated using a computerized statistical package (IBM SPSS ® Statistics 19.0, Armonk, New York, USA). All P values are two sided and the significance level was set at 0.05 throughout.
Results
Patient demographics and sleep registration results
A total of 96 MAS patients-28 females and 68 maleswere included, with the median age of 51.5 years (range: 20-72 years). They all had AHI index greater than 5/h Figure 1 Cephalometric points and lines used in the study. 1. The angle between the most posterior point on the anterior contour of the upper and lower alveolar processes and nasion; 2. Position of maxilla: the angle between the most posterior point on the anterior contour of the upper alveolar process, nasion, and sella; 3. Position of mandible: the angle between the most posterior point on the anterior contour of the lower alveolar process, nasion, and sella; 4. Maxillary length: the length from the temporomandibular joint to the anterior nasal spine; 5. Mandible length: the length from the temporomandibular joint to the gnathion; 6. Face height: the percentage of lower face height (anterior nasal spine to menton) to anterior face height (nasion to menton); 7. Jaw relation: the angle between the palatal plane (anterior nasal spine to posterior nasal spine) and mandible plane; 8. Sp1-sp2: the thickness of the soft palate; 9. Ve1-ve2: the minimal distance from the velum to the posterior pharyngeal wall; 10. P1-p2: the minimal distance from the tip of the uvula to the posterior pharyngeal wall; 11. Ph1-ph2: the shortest sagittal hypopharyngeal airway distance; 12. Hyoid: the shortest distance from the hyoid bone to the mandible.
(median 18.5/h; range 5.1-74.0/h). Median BMI was 27 kg/m 2 (range: 19-41 kg/m 2 ). Fifty-nine patients also had other co-morbidities, with 22 patients having arterial hypertension. The study population and the results of their sleep registrations are presented in Table 2 .
CPAP therapy
A total of 69 out of 96 patients had tried CPAP therapy before the MAS. This was defined by at least 1 month of CPAP usage trial. The reasons for abandoning CPAP were the lack of motivation, nasal symptoms, breathing discomfort, and discomfort related to air leak, futility of the device, and sleeping difficulties.
MAS therapy
After the clinical and radiographic analyses, 86 of the 96 OSA patients started MAS therapy; 10 patients did not start the treatment due to dental conditions (n = 5) or refusal (n = 5). The treatment success rate was 57% (49/86). The main problems with the MAS were pain in teeth (8/86, 10%), TMJ (9/86, 10%), or bite muscles (4/86, 5%); sleeping problems (3/86, 3%); irritation of the oral mucosa (7/86, 8%); dry mouth (3/86, 3%); and excessive salivation or vomiting (3/86, 3%). Thirty-four out of 86 patients (40%) had experienced problems with MAS. However, most of the problems were solved after the first few weeks.
The clinical dental and radiographic findings
Significant positive correlations with the compliance to the use of MAS were found in both maxillary and mandible lengths, i.e. the shorter the mesio-distal lengths of maxilla and/or mandible were, the better the patient adapted to the MAS. Other significant factors for compliance to MAS therapy were protrusion of the mandible with MAS during the adaptation to the appliance and crepitation of the right TMJ at the beginning of the treatment. The treatment compliance rate was 57%.
Sixty-nine per cent of the patients had convex profile. Forty-eight per cent had skeletal class I, 49% class II, and 3% class III. The face height was high in 62%, normal in 21%, and low in 17%. Jaw relation was closing in 49%, neutral in 15%, and opening in 36%. The clinical dental, facial, TMJ, and bite muscle findings, as well as panoramic, skeletal, and pharyngeal cephalometric radiographic results are presented in Tables 3 and 4) . BMI, body mass index; AHI, apnea-hypopnea index; MAS, Ph1-ph2, the shortest sagittal hypopharyngeal airway distance; Sp1-sp2, the thickness of the soft palate; Ve1-ve2, the minimal distance from the velum to the posterior pharyngeal wall; P1-p2, minimal distance from the tip of the uvula to the posterior pharyngeal wall; ANB, the angle between the most posterior point on the anterior contour of the upper and lower alveolar processes and nasion. 
Ideal patient for MAS therapy
The ideal patient model for MAS treatment did not show any significant differences in the created parameters. In the general aspects (male gender, BMI, AHI), most patients fulfilled the criteria in both MAS therapy groups. No differences in the clinical signs and radiographic points were encountered. The results of the ideal patient are shown in Table 5 .
Discussion
This study was carried out to identify the ideal OSA patients for MAS therapy. The data were analysed to find the possible predictive factors for compliance to use the appliance and thus to help the referring physicians to select suitable patients. Ultimately, this would increase cost-effectiveness of the management process. The treatment compliance rate in the present study was 57%, which corresponds well with the reported rates ranging from 56 to 70% (Hoffstein, 2007; Hoekema et al., 2008; Ahrens et al., 2010) . In most studies, the compliance rate of MAS is based on the decrease of AHI with MAS (Johal et al., 2007; Lettieri et al., 2011) . The present study focused on finding patients who would best adapt to MAS appliance treatment. We currently send our patients to sleep registration with the MAS appliance after they have shown compliance with it for at least 6 months. In that stage, protrusion of MAS can be adjusted to obtain the best possible amount of AHI reduction. The present results showed significant positive correlation for both maxillary and mandible lengths for compliance to MAS use, i.e. the shorter the mesio-distal lengths of maxilla and/or mandible were, the better the patient adapted to the MAS. The results did not show significant differences in other skeletal or pharyngeal cephalometric values between the compliant and non-compliant patients. However, a trend for retrognathic position of maxilla was present in the compliant MAS group. The dominating skeletal structures in both groups were retrognathic position of the mandible, high face height, and closing jaw relationship. This might result from the selected group of patients being prone to Table 3 The clinical facial, dental, temporomandibular joint, and bite muscle parameters in patients with compliant/noncompliant MAS therapy. The treatment compliance rate was defined as regular use of the appliance for at least 6 months. The results are expressed as median and range (N = 96); in some patients, all investigated records were not documented. -sp2 (mm) 9.1 (4.9-31.9) 9.7 (4.3-18.5) 0. , and retrognathic (r); face height h, n, l-the percentage of lower face height to anterior face height, high (h), normal (n), and low (l); jaw relation c, n, o-the angle between the palatal plane and mandible plane, closing (c), neutral (n), and opening (o); Sp1-sp2, the thickness of the soft palate; ; Ve1-ve2, the minimal distance from the velum to the posterior pharyngeal wall; P1-p2, the minimal distance from the tip of the uvula to the posterior pharyngeal wall; Ph1-ph2, the shortest sagittal hypopharyngeal airway distance; hyoid, the shortest distance from the hyoid bone to the mandible; MAS, mandible advancement splint.
Table 5
The results of the indices used for the ideal patient.
Index
Successful MAS Failed MAS P value develop sleep apnea due to their skeletal and/or pharyngeal structures, which have been shown to be typical for OSA patients (Tangugsorn et al., 1995) . On the contrary, Liu et al. (2008) showed that a better treatment response was achieved with MAS in patients with a longer maxilla and a smaller oropharyngeal space. According to Ng et al. (2012) , shorter soft palate length, increased cranial base angulation, younger age, and female gender were found to be predictive of MAS treatment success. The homologous cephalometric results between the compliant and noncompliant groups, found in the present study, question the need for cephalometric radiographs when considering a patient suitable for MAS therapy.
Cranial base length has also been found to be important for the MAS treatment outcome (Liu et al., 2001) . Growth of the cranial base has direct effects on the middle face and mandible. As the cranial base and clivus elongate, there is corresponding enlargement of the nasomaxillary complex, anterior displacement of the middle face, enlargement of the pharynx, and enlargement of the mandible ramus, causing anterior displacement of the mandible arch and maxilla (Ng et al., 2012) .
Previous studies have shown the importance of skeletal and pharyngeal (adenoids, tonsils, soft palate) structures, which predispose to possible development of OSA. These signs should be taken care of by an orthodontist and otorhinolaryngologist already in the developmental phase of the face, jaw, occlusion, and pharyngeal structures, i.e. adenoids and tonsils, during growth. In addition, facial structures should be clinically studied when considering the MAS treatment option (Tangugsorn et al., 1995; Ingman et al., 2004; Liu and Lowe, 2000; Lee et al., 2010) .
Significant difference in compliant use of MAS, compared with unsuccessful use, was also found regarding additional protrusion of the mandible with MAS during adaptation to the appliance. Similarly, patients having crepitatation of the right TMJ at the beginning of the treatment were found to adapt better to MAS therapy. Thus, use of MAS might be associated with reduction of the symptoms of tooth bruxism (Landry et al., 2006) . Our statistical analysis showed a significant effect of the presence of the right TMJ crepitation with MAS. Meanwhile, we do not have any physiopathological explanation to our finding. We may consider it a coincidence. Nevertheless, we noticed that some of our patients with TMJ problems do benefit from MAS. This should be taken into consideration in patients with mild OSA when assessing the suitable sleep apnea treatment, i.e. CPAP or MAS, for the patient.
The achieved advancement of the mandible seems to be essential for the success rate of the treatment. Gindre et al. (2008) pointed out that improvement in AHI during MAS therapy is dependent on the amount of mandible advancement. Thus, adjustment of mandible advancement is an important part of the treatment. In addition, patients are shown to tolerate the side-effects of MAS better when the AHI is remarkably decreased (Gindre et al., 2008; Ahrens et al., 2010) . Zeng et al. (2008) found that higher levels of nasal resistance may have a negative impact on treatment outcome with MAS. Thus, consultation with an otorhinolaryngologist should be mandatory before MAS treatment. The present study could not show the effect of nasal airway pressure in MAS therapy due to the fact that only a few patients underwent nasal operations before the MAS treatment. Tsuiki et al. (2010) found that OSA patients with a CPAP pressure of 10.5 cmH 2 O are unlikely to respond to oral appliance therapy. The present results do not confirm their results. This may be due to the methodology because they evaluated the success by a sleep study.
To our knowledge, no previous studies have addressed the unnecessary costs created by MAS therapy for patients who do not tolerate or refuse to use the appliance. The costs for one MAS therapy, including clinical, laboratory, and radiographic expenses, are approximately 800-1000€. Thus, the annual total costs for unsuccessful MAS therapies at our institution in the year 2008 were approximately 38 000€, which further highlights the importance of proper patient selection. The assessment of the above costs should be considered with caution as we did not obtain an objective evaluation of the outcome of MAS therapy.
Our study has nevertheless some limitations: first, the nature of the study was retrospective, which somewhat limited us from drawing solid conclusions. Second, our definition of the compliance of MAS therapy is arbitrary and relies only on the patient's history. Third, our patient population is not homogeneous, as we had proposed the MAS for those in whom the CPAP therapy was considered unsuitable or disturbing. Finally, we did not ensure the efficacy of the MAS therapy by a sleep study. There is some evidence that the compliance rate of the MAS is higher in patients presenting positional sleep apnea (Ravesloot et al., 2012) .
In conclusion, the useful predictive factors for determining the suitability of OSA patient for MAS might be diminished maxillary and mandible lengths. However, according to our results, other medical, dental, or cephalometric factors investigated in the present study were not significant in predicting the success of MAS therapy in OSA patients due to the already-kindred patient group. Second, when considering the ideal amount of mandible protrusion, in addition to clinical experience, the patient should be investigated with a sleep study in combination with MAS use.
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